Atherosclerosis Forum-3
|
08:00-10:00 207 |
|---|
| 主持 Moderators | 曲新凯 Xinkai QU, 陆士娟 Shijuan LU, 何正飞 Zhengfei HE, 吴斌 Bin WU, 叶军 Jun YE | ||
|
08:00-08:20 |
脂代谢紊乱与动脉粥样硬化 Lipid Metabolism Disorders and Atherosclerosis |
杨伟宪 Weixian YANG | |
|
08:20-08:40 |
HDL与心血管获益-现状与未来 HDL and Cardiovascular Benefits - Current Status and Future |
严晓伟 Xiaowei YAN | |
|
08:40-09:00 |
AS抗炎治疗的临床研究进展 Clinical Research Progress of Anti-Inflammatory Treatment for Atherosclerosis |
杨人强 Renqiang YANG | |
|
09:00-09:20 |
由表及里，GLP-1RA在ASCVD合并糖尿病治疗中的获益机制 From Surface to Essence: Benefit Mechanism of GLP-1RA in the Treatment of ASCVD Complicated with Diabetes Mellitus |
张英梅 Yingmei ZHANG | |
|
09:20-09:40 |
经脑心轴干预动脉粥样硬化疾病的探索与发现 Exploration and Discovery of Intervening Atherosclerotic Diseases Through the Brain-Heart Axis |
于雪 Xue YU | |
|
09:40-10:00 |
稳定和逆转冠状动脉粥样硬化斑块的治疗研究进展 Research Progress in the Treatment of Stabilizing and Reversing Coronary Atherosclerotic Plaques |
郭彩霞 Caixia GUO | |
Atherosclerosis Forum-4
|
10:00-12:00 207 |
|---|
| 主持 Moderators | 毛威 Wei MAO, 寿锡凌 Xiling SHOU, 黄抒伟 Shuwei HUANG, 魏文娟 Wenjuan WEI, 成银宏 Yinhong CHENG, 陈建明 Jianming CHEN | ||
|
10:00-10:20 |
从指南到临床看ASCVD血脂管理革新与变迁 Innovation and Changes in ASCVD Lipid Management from Guidelines to Clinical Practice |
李建军 Jianjun LI | |
|
10:20-10:40 |
2025ESC 血脂管理新视野：起始联合治疗的循证证据与实践 2025 ESC New Horizons in Lipid Management: Evidence and Practice of Initial Combination Therapy |
徐标 Biao XU | |
|
10:40-11:00 |
从“心肾代谢综合征”新理念，探寻疾病综合管理之路 Exploring Integrated Disease Management: Insights from the Novel Concept of Cardiorenal Metabolic Syndrome |
王连生 Liansheng WANG | |
|
11:00-11:20 |
LP（a）-降脂领域的下一个热点？ LP (a) - The Next Hot Topic in Lipid-Lowering Field? |
黄进宇 Jinyu HUANG | |
|
11:20-11:40 |
从指南更新看 ACS 患者降脂达标管理 Lipid Management in ACS: Insights from Guideline Updates |
胡惠林 Huilin HU | |
|
11:40-12:00 |
从指南更新看 CCS 患者降脂达标策略 Lipid-Lowering Target Achievement Strategy for CCS Patients from the Perspective of Guideline Updates |
梅益斌 Yibin MEI | |
Metabolic & CVD Forum-1
|
13:30-15:30 207 |
|---|
| 主持 Moderators | 李浪 Lang LI, 王长谦 Changqian WANG, 王永光 Yongguang WANG, 李小成 Xiaocheng LI | ||
|
13:30-13:50 |
心血管疾病合并慢性肾脏病早期筛查及规范管理专家共识解读 Interpretation of the Expert Consensus on Early Screening and Standardized Management of Cardiovascular Disease Complicated by Chronic Kidney Disease |
陈纪言 Jiyan CHEN | |
|
13:50-14:10 |
GLP-1受体激动剂：超越降糖的心血管获益新纪元/心肾代谢综合征的整合管理 GLP-1 Receptor Agonists: A New Era of Cardiovascular Benefits Beyond Glycemic Control / Integrated Management of Cardiorenal Metabolic Syndrome |
郑杨 Yang ZHENG | |
|
14:10-14:30 |
射血分数保留的心衰患者治疗进展 Advances in the Treatment of Heart Failure with Preserved Ejection Fraction |
吴高俊 Gaojun WU | |
|
14:30-14:50 |
CKM与颈动脉体—机制与干预 CKM and the Carotid Body: Mechanisms and Interventions |
黄晶 Jing HUANG | |
|
14:50-15:10 |
器官交互与代谢衰老 Organ Crosstalk and Metabolic Aging |
卜军 Jun BU | |
|
15:10-15:30 |
心血管代谢学：从学科构建到临床实践的演进/冠心病合并代谢紊乱的介入治疗策略 Cardiometabolic Medicine: Evolution from Discipline Development to Clinical Practice / Interventional Strategies for Coronary Artery Disease with Metabolic Disorders |
唐熠达 Yida TANG | |
Metabolic & CVD Forum-2
|
15:30-17:30 207 |
|---|
| 主持 Moderators | 董建增 Jianzeng DONG, 宋雷 Lei SONG, 柴东升 Dongsheng CHAI, 李亚 Ya LI, 江帆 Fan JIANG, 刘强 Qiang LIU | ||
|
15:30-15:50 |
TBD | 定 待 | |
|
15:50-16:10 |
慢性炎症、肠道菌群与动脉粥样硬化 Chronic Inflammation, Gut Microbiota, and Atherosclerosis |
曲鹏 Peng QU | |
|
16:10-16:30 |
GLP-1RA在肥胖合并HFpEF中的研究进展 Research Progress on GLP-1 Receptor Agonists in Obesity with Heart Failure with Preserved Ejection Fraction (HFpEF) |
寿锡凌 Xiling SHOU | |
|
16:30-16:50 |
舒张期高血压和代谢综合征 Diastolic Hypertension and Metabolic Syndrome |
谢良地 Liangdi XIE | |
|
16:50-17:10 |
动脉粥样硬化抗炎症治疗 Anti-inflammatory Therapy for Atherosclerosis |
车文良 Wenliang CHE | |
|
17:10-17:30 |
⼈⼯⾎管研究进展 Progress in Artificial Vascular Grafts |
孔德领 Deling KONG | |